Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.
Abstract |
Muscarinic agonists might be useful in the treatment of neurological disorders, including Alzheimer's disease, schizophrenia, chronic pain, and drug abuse. Previous studies identified a series of bis-1,2,5-thiadiazole derivatives of 1,2,5,6-tetrahydropyridine with high activity and selectivity for muscarinic receptors. To develop compounds with improved central nervous system penetration, several new derivatives were synthesized and characterized for muscarinic receptor binding and activity. One ligand (11) exhibited agonist activity at M(1), M(2), and M(4) receptors, a selectivity profile suggesting potential utility in the treatment of schizophrenia.
|
Authors | Yang Cao, Minjia Zhang, Cindy Wu, Selina Lee, Mary Elizabeth Wroblewski, Trisha Whipple, Peter I Nagy, Krisztina Takács-Novák, Attila Balázs, Szilárd Torös, William S Messer Jr |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 46
Issue 20
Pg. 4273-86
(Sep 25 2003)
ISSN: 0022-2623 [Print] United States |
PMID | 13678406
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Benzilates
- Muscarinic Agonists
- Pyridines
- Receptors, Muscarinic
- Thiadiazoles
- Colforsin
- Carbachol
- Cyclic AMP
|
Topics |
- Animals
- Benzilates
(antagonists & inhibitors, chemistry)
- Binding, Competitive
- CHO Cells
- Carbachol
(pharmacology)
- Cell Line
- Colforsin
(antagonists & inhibitors, pharmacology)
- Cricetinae
- Cyclic AMP
(metabolism)
- Humans
- Hypothermia
(chemically induced)
- Male
- Mice
- Models, Molecular
- Muscarinic Agonists
(chemical synthesis, metabolism, pharmacology)
- Nervous System Diseases
(drug therapy)
- Pyridines
(chemical synthesis, chemistry, metabolism, pharmacology)
- Radioligand Assay
- Rats
- Rats, Long-Evans
- Receptors, Muscarinic
(metabolism)
- Thiadiazoles
(chemical synthesis, chemistry, metabolism, pharmacology)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|